New method for delivering proteins directly into cells
SUPRAMOLECULAR PEPTIDE CO-ASSEMBLIES FOR CYTOSOLIC PROTEIN DELIVERY
This study is working on a new way to deliver helpful proteins directly into cells, which could make treatments for different health conditions more effective and reliable.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10704128 on NIH RePORTER |
What this research studies
This research focuses on developing a novel vehicle that can efficiently deliver therapeutic proteins directly into the cytosol of cells. By using pairs of oppositely-charged synthetic peptides that co-assemble into nanofibers, the project aims to create a system that can transport proteins regardless of their size or charge. This approach seeks to overcome the limitations of traditional protein delivery methods, which often fail due to the proteins' large size and hydrophilicity. The goal is to ensure that these proteins remain active and are not degraded during transport, ultimately improving treatment options for various conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions that could benefit from targeted protein therapies, such as certain cancers or autoimmune diseases.
Not a fit: Patients who do not have conditions that require protein-based therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective therapies by enabling faster and more reliable delivery of proteins that target specific diseases.
How similar studies have performed: While the approach of using synthetic peptides for protein delivery is innovative, similar strategies have shown promise in preliminary studies, indicating potential for success.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Hudalla, Gregory — University of Florida
- Study coordinator: Hudalla, Gregory
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.